142 related articles for article (PubMed ID: 9242658)
1. Ca2+ binding to the first epidermal growth factor-like domain of factor VIIa increases amidolytic activity and tissue factor affinity.
Persson E; Olsen OH; Ostergaard A; Nielsen LS
J Biol Chem; 1997 Aug; 272(32):19919-24. PubMed ID: 9242658
[TBL] [Abstract][Full Text] [Related]
2. High affinity Ca(2+)-binding site in the serine protease domain of human factor VIIa and its role in tissue factor binding and development of catalytic activity.
Sabharwal AK; Birktoft JJ; Gorka J; Wildgoose P; Petersen LC; Bajaj SP
J Biol Chem; 1995 Jun; 270(26):15523-30. PubMed ID: 7797546
[TBL] [Abstract][Full Text] [Related]
3. Ca2+ in the first epidermal growth factor-like domain of activated factor VII.
Persson E; Nielsen LS
Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S79-81. PubMed ID: 9819033
[TBL] [Abstract][Full Text] [Related]
4. Ca2+ binding to the first epidermal growth factor module of coagulation factor VIIa is important for cofactor interaction and proteolytic function.
Kelly CR; Dickinson CD; Ruf W
J Biol Chem; 1997 Jul; 272(28):17467-72. PubMed ID: 9211891
[TBL] [Abstract][Full Text] [Related]
5. Structurally and functionally distinct Ca2+ binding sites in the gamma-carboxyglutamic acid-containing domain of factor VIIa.
Persson E; Petersen LC
Eur J Biochem; 1995 Nov; 234(1):293-300. PubMed ID: 8529655
[TBL] [Abstract][Full Text] [Related]
6. Functional consequences of mutations in Ser-52 and Ser-60 in human blood coagulation factor VII.
Iino M; Foster DC; Kisiel W
Arch Biochem Biophys; 1998 Apr; 352(2):182-92. PubMed ID: 9587405
[TBL] [Abstract][Full Text] [Related]
7. Interaction of calcium with native and decarboxylated human factor X. Effect of proteolysis in the autolysis loop on catalytic efficiency and factor Va binding.
Sabharwal AK; Padmanabhan K; Tulinsky A; Mathur A; Gorka J; Bajaj SP
J Biol Chem; 1997 Aug; 272(35):22037-45. PubMed ID: 9268343
[TBL] [Abstract][Full Text] [Related]
8. Isolation and characterization of proteolytic fragments of human factor VIIa which inhibit the tissue factor-enhanced amidolytic activity of factor VIIa.
Kazama Y; Pastuszyn A; Wildgoose P; Hamamoto T; Kisiel W
J Biol Chem; 1993 Aug; 268(22):16231-40. PubMed ID: 8344908
[TBL] [Abstract][Full Text] [Related]
9. Factor VIIa's first epidermal growth factor-like domain's role in catalytic activity.
Jin J; Chang J; Chang JY; Kelley RF; Stafford DW; Straight DL
Biochemistry; 1999 Jan; 38(4):1185-92. PubMed ID: 9930978
[TBL] [Abstract][Full Text] [Related]
10. First epidermal growth factor-like domain of human blood coagulation factor IX is required for its activation by factor VIIa/tissue factor but not by factor XIa.
Zhong D; Smith KJ; Birktoft JJ; Bajaj SP
Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3574-8. PubMed ID: 8170949
[TBL] [Abstract][Full Text] [Related]
11. The N-terminal epidermal growth factor-like domain in factor IX and factor X represents an important recognition motif for binding to tissue factor.
Zhong D; Bajaj MS; Schmidt AE; Bajaj SP
J Biol Chem; 2002 Feb; 277(5):3622-31. PubMed ID: 11723140
[TBL] [Abstract][Full Text] [Related]
12. Binding of Zn2+ to a Ca2+ loop allosterically attenuates the activity of factor VIIa and reduces its affinity for tissue factor.
Petersen LC; Olsen OH; Nielsen LS; Freskgård PO; Persson E
Protein Sci; 2000 May; 9(5):859-66. PubMed ID: 10850795
[TBL] [Abstract][Full Text] [Related]
13. Identification of a calcium binding site in the protease domain of human blood coagulation factor VII: evidence for its role in factor VII-tissue factor interaction.
Wildgoose P; Foster D; Schiødt J; Wiberg FC; Birktoft JJ; Petersen LC
Biochemistry; 1993 Jan; 32(1):114-9. PubMed ID: 8418832
[TBL] [Abstract][Full Text] [Related]
14. Spectroscopic probing of the influence of calcium and the gla domain on the interaction between the first EGF domain in factor VIIa and tissue factor.
Osterlund M; Owenius R; Persson E; Lindgren M; Carlsson U; Freskgård PO; Svensson M
Eur J Biochem; 2000 Oct; 267(20):6204-11. PubMed ID: 11012674
[TBL] [Abstract][Full Text] [Related]
15. Similar molecular interactions of factor VII and factor VIIa with the tissue factor region that allosterically regulates enzyme activity.
Kelley RF; Yang J; Eigenbrot C; Moran P; Peek M; Lipari MT; Kirchhofer D
Biochemistry; 2004 Feb; 43(5):1223-9. PubMed ID: 14756558
[TBL] [Abstract][Full Text] [Related]
16. Substitution of aspartic acid for methionine-306 in factor VIIa abolishes the allosteric linkage between the active site and the binding interface with tissue factor.
Persson E; Nielsen LS; Olsen OH
Biochemistry; 2001 Mar; 40(11):3251-6. PubMed ID: 11258943
[TBL] [Abstract][Full Text] [Related]
17. Structural changes in factor VIIa induced by Ca2+ and tissue factor studied using circular dichroism spectroscopy.
Freskgård PO; Olsen OH; Persson E
Protein Sci; 1996 Aug; 5(8):1531-40. PubMed ID: 8844844
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the interaction between the light chain of factor VIIa and tissue factor.
Persson E
FEBS Lett; 1997 Aug; 413(2):359-63. PubMed ID: 9280313
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the functions of the first epidermal growth factor-like domain of factor X.
Rezaie AR; Neuenschwander PF; Morrissey JH; Esmon CT
J Biol Chem; 1993 Apr; 268(11):8176-80. PubMed ID: 8463328
[TBL] [Abstract][Full Text] [Related]
20. Identification of surface residues mediating tissue factor binding and catalytic function of the serine protease factor VIIa.
Dickinson CD; Kelly CR; Ruf W
Proc Natl Acad Sci U S A; 1996 Dec; 93(25):14379-84. PubMed ID: 8962059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
